DAVITA INC. Operating Cash Flow
DAVITA INC. (DVA) reported Operating Cash Flow of $810.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-04
- DAVITA INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $490.07M, a 51.15% increase year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $320.83M, a 78.23% increase year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $540.73M, a 1.26% decline year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $841.53M, a 3.84% increase year-over-year.
- DAVITA INC. net cash provided by (used in) operating activities for fiscal 2025 was $1.89B, a 6.70% decline from fiscal 2024.
- DAVITA INC. net cash provided by (used in) operating activities for fiscal 2024 was $2.02B, a 1.80% decline from fiscal 2023.
- DAVITA INC. net cash provided by (used in) operating activities for fiscal 2023 was $2.06B, a 31.60% increase from fiscal 2022.
- DAVITA INC. net cash provided by (used in) operating activities for fiscal 2022 was $1.56B, a 18.97% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $490.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $810.90M 10-Q · filed 2026-08-04 | $1.35B derived: sum of 3 quarters · filed 2026-08-04 | $2.19B derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $320.83M 10-Q · filed 2026-05-05 | $861.56M derived: sum of 2 quarters · filed 2026-05-05 | $1.70B derived: sum of 3 quarters · filed 2026-05-05 | $2.03B derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $540.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.38B derived: sum of 2 quarters · filed 2026-02-11 | $1.71B derived: sum of 3 quarters · filed 2026-08-04 | $1.89B 10-K · filed 2026-02-11 | |
| 2025-09-30 | $841.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.17B derived: sum of 2 quarters · filed 2026-08-04 | $1.35B 10-Q · filed 2025-10-29 | $1.89B derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $324.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $504.25M 10-Q · filed 2026-08-04 | $1.05B derived: sum of 3 quarters · filed 2026-08-04 | $1.86B derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $180.01M 10-Q · filed 2026-05-05 | $727.64M derived: sum of 2 quarters · filed 2026-05-05 | $1.54B derived: sum of 3 quarters · filed 2026-05-05 | $2.34B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $547.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.36B derived: sum of 2 quarters · filed 2026-02-11 | $2.16B derived: sum of 3 quarters · filed 2026-02-11 | $2.02B 10-K · filed 2026-02-11 | |
| 2024-09-30 | $810.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.61B derived: sum of 2 quarters · filed 2025-10-29 | $1.47B 10-Q · filed 2025-10-29 | $1.96B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | $798.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $664.01M 10-Q · filed 2025-08-05 | $1.15B derived: sum of 3 quarters · filed 2026-02-11 | $1.81B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | -$134.84M 10-Q · filed 2025-05-12 | $350.37M derived: sum of 2 quarters · filed 2026-02-11 | $1.01B derived: sum of 3 quarters · filed 2026-02-11 | $1.46B derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | $485.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.15B derived: sum of 2 quarters · filed 2026-02-11 | $1.60B derived: sum of 3 quarters · filed 2026-02-11 | $2.06B 10-K · filed 2026-02-11 | |
| 2023-09-30 | $661.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $1.11B derived: sum of 2 quarters · filed 2024-10-29 | $1.57B 10-Q · filed 2024-10-29 | $1.92B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | $450.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $912.66M 10-Q · filed 2024-08-06 | $1.26B derived: sum of 3 quarters · filed 2025-02-13 | $1.97B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $462.56M 10-Q · filed 2024-05-02 | $806.28M derived: sum of 2 quarters · filed 2025-02-13 | $1.52B derived: sum of 3 quarters · filed 2025-02-13 | $1.70B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | $343.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.05B derived: sum of 2 quarters · filed 2025-02-13 | $1.24B derived: sum of 3 quarters · filed 2025-02-13 | $1.56B 10-K · filed 2025-02-13 | |
| 2022-09-30 | $710.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $898.65M derived: sum of 2 quarters · filed 2023-11-07 | $1.22B 10-Q · filed 2023-11-07 | $1.75B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-06-30 | $188.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $510.32M 10-Q · filed 2023-08-03 | $1.04B derived: sum of 3 quarters · filed 2024-02-14 | $1.61B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2022-03-31 | $322.19M 10-Q · filed 2023-05-08 | $852.08M derived: sum of 2 quarters · filed 2024-02-14 | $1.42B derived: sum of 3 quarters · filed 2024-02-14 | $2.10B derived: sum of 4 quarters · filed 2024-02-14 | |
| 2021-12-31 | $529.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $1.10B derived: sum of 2 quarters · filed 2024-02-14 | $1.78B derived: sum of 3 quarters · filed 2024-02-14 | $1.93B 10-K · filed 2024-02-14 | |
| 2021-09-30 | $566.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | $1.25B derived: sum of 2 quarters · filed 2022-10-31 | $1.40B 10-Q · filed 2022-10-31 | $1.89B derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $679.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $834.04M 10-Q · filed 2022-08-01 | $1.32B derived: sum of 3 quarters · filed 2023-02-22 | $1.80B derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | $154.30M 10-Q · filed 2022-05-05 | $639.10M derived: sum of 2 quarters · filed 2023-02-22 | $1.12B derived: sum of 3 quarters · filed 2023-02-22 | $1.77B derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $484.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $967.52M derived: sum of 2 quarters · filed 2023-02-22 | $1.62B derived: sum of 3 quarters · filed 2023-02-22 | $1.98B 10-K · filed 2023-02-22 | |
| 2020-09-30 | $482.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.13B derived: sum of 2 quarters · filed 2021-10-28 | $1.49B 10-Q · filed 2021-10-28 | $2.17B derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-06-30 | $651.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.01B 10-Q · filed 2021-08-03 | $1.69B derived: sum of 3 quarters · filed 2022-02-11 | $2.33B derived: sum of 4 quarters · filed 2022-02-11 | |
| 2020-03-31 | $360.38M 10-Q · filed 2021-04-29 | $1.04B derived: sum of 2 quarters · filed 2022-02-11 | $1.68B derived: sum of 3 quarters · filed 2022-02-11 | $2.29B derived: sum of 4 quarters · filed 2022-02-11 | |
| 2019-12-31 | $680.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $1.32B derived: sum of 2 quarters · filed 2022-02-11 | $1.93B derived: sum of 3 quarters · filed 2022-02-11 | $2.07B 10-K · filed 2022-02-11 | |
| 2019-09-30 | $640.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.25B derived: sum of 2 quarters · filed 2020-10-29 | $1.39B 10-Q · filed 2020-10-29 | $1.78B derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | $609.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $751.12M 10-Q · filed 2020-07-30 | $1.14B derived: sum of 3 quarters · filed 2021-02-12 | $1.60B derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | $141.30M 10-Q · filed 2020-05-05 | $530.70M derived: sum of 2 quarters · filed 2021-02-12 | $988.37M derived: sum of 3 quarters · filed 2021-02-12 | $1.55B derived: sum of 4 quarters · filed 2021-02-12 | |
| 2018-12-31 | $389.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $847.07M derived: sum of 2 quarters · filed 2021-02-12 | $1.41B derived: sum of 3 quarters · filed 2021-02-12 | $1.77B 10-K · filed 2021-02-12 | |
| 2018-09-30 | $457.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.02B derived: sum of 2 quarters · filed 2019-11-07 | $1.38B 10-Q · filed 2019-11-07 | $1.73B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-06-30 | $562.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $924.58M 10-Q · filed 2019-08-02 | $1.27B derived: sum of 3 quarters · filed 2020-02-21 | $1.82B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2018-03-31 | $362.54M 10-Q · filed 2019-05-07 | $707.55M derived: sum of 2 quarters · filed 2020-02-21 | $1.26B derived: sum of 3 quarters · filed 2020-02-21 | $1.41B derived: sum of 4 quarters · filed 2020-02-21 | |
| 2017-12-31 | $345.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $898.11M derived: sum of 2 quarters · filed 2020-02-21 | $1.05B derived: sum of 3 quarters · filed 2020-02-21 | $1.91B 10-K · filed 2020-02-21 | $1.91B 10-K · filed 2018-02-23 |
| 2017-09-30 | $553.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $702.98M derived: sum of 2 quarters · filed 2018-11-07 | $1.57B 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $149.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.02B 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $865.17M 10-Q · filed 2018-05-03 | ||||
| 2016-12-31 | $1.97B 10-K · filed 2019-02-22 | $1.96B 10-K · filed 2018-02-23 | |||
| 2015-12-31 | $1.56B 10-K · filed 2018-02-23 | ||||
| 2015-03-31 | $410.09M 10-Q/A · filed 2015-05-08 | $340.10M derived: sum of 2 quarters · filed 2015-05-08 | $1.19B derived: sum of 3 quarters · filed 2015-05-08 | $1.45B derived: sum of 4 quarters · filed 2015-05-08 | |
| 2014-12-31 | -$69.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $777.91M derived: sum of 2 quarters · filed 2015-02-26 | $1.04B derived: sum of 3 quarters · filed 2015-02-26 | $1.46B 10-K · filed 2015-02-26 | |
| 2014-09-30 | $847.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.11B derived: sum of 2 quarters · filed 2014-11-06 | $1.53B 10-Q · filed 2014-11-06 | $1.88B derived: sum of 4 quarters · filed 2015-05-08 | |
| 2014-06-30 | $262.39M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-08-01 | $681.50M 10-Q · filed 2014-08-01 | $1.04B derived: sum of 3 quarters · filed 2015-05-08 | $1.77B derived: sum of 4 quarters · filed 2015-05-08 | |
| 2014-03-31 | $419.11M 10-Q/A · filed 2015-05-08 | $773.29M derived: sum of 2 quarters · filed 2015-05-08 | $1.51B derived: sum of 3 quarters · filed 2015-05-08 | $1.81B derived: sum of 4 quarters · filed 2015-05-08 | |
| 2013-12-31 | $354.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.09B derived: sum of 2 quarters · filed 2015-02-26 | $1.39B derived: sum of 3 quarters · filed 2015-02-26 | $1.77B 10-K · filed 2015-02-26 | |
| 2013-09-30 | $733.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.04B derived: sum of 2 quarters · filed 2014-11-06 | $1.42B 10-Q · filed 2014-11-06 | $1.62B derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | $306.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $686.03M 10-Q · filed 2014-08-01 | $886.26M derived: sum of 3 quarters · filed 2015-02-26 | $1.25B derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | $379.21M 10-Q · filed 2014-05-02 | $579.44M derived: sum of 2 quarters · filed 2015-02-26 | $946.08M derived: sum of 3 quarters · filed 2015-02-26 | $1.15B derived: sum of 4 quarters · filed 2015-02-26 | |
| 2012-12-31 | $200.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $566.87M derived: sum of 2 quarters · filed 2015-02-26 | $768.97M derived: sum of 3 quarters · filed 2015-02-26 | $1.10B 10-K · filed 2015-02-26 | |
| 2012-09-30 | $366.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $568.74M derived: sum of 2 quarters · filed 2013-11-06 | $900.61M 10-Q · filed 2013-11-06 | $1.05B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-06-30 | $202.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $533.98M 10-Q · filed 2013-08-07 | $684.64M derived: sum of 3 quarters · filed 2014-02-21 | $1.18B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2012-03-31 | $331.87M 10-Q · filed 2013-05-09 | $482.53M derived: sum of 2 quarters · filed 2014-02-21 | $977.73M derived: sum of 3 quarters · filed 2014-02-21 | $1.18B derived: sum of 4 quarters · filed 2014-02-21 | |
| 2011-12-31 | $150.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $645.85M derived: sum of 2 quarters · filed 2014-02-21 | $850.26M derived: sum of 3 quarters · filed 2014-02-21 | $1.18B 10-K · filed 2014-02-21 | |
| 2011-09-30 | $495.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $699.60M derived: sum of 2 quarters · filed 2012-10-31 | $1.03B 10-Q · filed 2012-10-31 | $1.15B derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-06-30 | $204.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $534.19M 10-Q · filed 2012-08-03 | $654.74M derived: sum of 3 quarters · filed 2013-03-01 | $816.11M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2011-03-31 | $329.78M 10-Q · filed 2012-05-02 | $450.33M derived: sum of 2 quarters · filed 2013-03-01 | $611.70M derived: sum of 3 quarters · filed 2013-03-01 | $907.62M derived: sum of 4 quarters · filed 2013-03-01 | |
| 2010-12-31 | $120.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $281.92M derived: sum of 2 quarters · filed 2013-03-01 | $577.84M derived: sum of 3 quarters · filed 2013-03-01 | $839.68M 10-K · filed 2013-03-01 | |
| 2010-09-30 | $161.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $457.29M derived: sum of 2 quarters · filed 2011-11-04 | $719.13M 10-Q · filed 2011-11-04 | $871.72M derived: sum of 4 quarters · filed 2012-07-06 | |
| 2010-06-30 | $295.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $557.77M 10-Q · filed 2011-08-04 | $710.36M derived: sum of 3 quarters · filed 2012-07-06 | $877.84M derived: sum of 4 quarters · filed 2012-07-06 | |
| 2010-03-31 | $261.85M 10-Q · filed 2011-05-06 | $414.44M derived: sum of 2 quarters · filed 2012-07-06 | $581.92M derived: sum of 3 quarters · filed 2012-07-06 | $794.31M derived: sum of 4 quarters · filed 2012-07-06 | |
| 2009-12-31 | $152.59M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | $320.08M derived: sum of 2 quarters · filed 2012-07-06 | $532.46M derived: sum of 3 quarters · filed 2012-07-06 | $666.71M 8-K · filed 2012-07-06 | |
| 2009-09-30 | $167.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $379.87M derived: sum of 2 quarters · filed 2010-11-05 | $514.12M 10-Q · filed 2010-11-05 | $712.67M derived: sum of 4 quarters · filed 2011-02-25 | |
| 2009-06-30 | $212.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $346.63M 10-Q · filed 2010-08-05 | $545.18M derived: sum of 3 quarters · filed 2011-02-25 | $705.38M derived: sum of 4 quarters · filed 2011-02-25 | |
| 2009-03-31 | $134.25M 10-Q · filed 2010-05-03 | $332.80M derived: sum of 2 quarters · filed 2011-02-25 | $492.99M derived: sum of 3 quarters · filed 2011-02-25 | ||
| 2008-12-31 | $198.55M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $358.74M derived: sum of 2 quarters · filed 2011-02-25 | $613.70M 10-K · filed 2011-02-25 | ||
| 2008-09-30 | $160.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $415.15M 10-Q · filed 2009-11-05 | |||
| 2008-06-30 | $254.96M 10-Q · filed 2009-08-07 | ||||
| 2007-12-31 | $581.07M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |